Search

The article discusses the concept of personalized medicine, also known as precision medicine, and its relationship to rising drug prices and declining healthcare quality in the United States. The author, James Tabery, argues that personalized medicine has been oversold and that more focus should be placed on environmental studies to improve public health. However, the author of the summary disagrees with Tabery's arguments, stating that blaming rising drug prices solely on personalized medicine is misguided and that the pharmaceutical industry's profit-driven motives are a major factor. The summary also mentions the success stories of personalized medicine, such as the development of drugs tailored to specific genetic mutations. [Extracted from the article]

This article describes a program session that focused on publishers’ experiences launching Open Access (OA) journals and lessons learned. The speakers discussed the current journal marketplace, current journal business models, and the possible shape of the OA landscape and marketplace in the future. [ABSTRACT FROM PUBLISHER]